Leydig cell ovarian tumor – clinical case description and literature review

Leydig cell ovarian tumors constitute not only a medical problem for clinicians but also a social problem – which is why women with symptoms of hirsutism relatively quickly contact physicians for medical consultation. Leydig cell ovarian tumor is a rare sex cord-gonadal stromal tumor which constitutes less than 0.5% of ovarian tumors. These cancers appear at all ages but the majority of the cases concern women in the perimenopause. In the majority of cases (70-85%), the growth is accompanied by androgen secretion, together with virilization and hirsutism. The presence of hormonally active ovarian cancers should be suspected in cases of rapidly growing symptoms of masculinization, especially when the level of free testosterone in the blood exceeds the upper limit for the given age more than three times. In diagnosing postmenopausal hyperandrogenism, it is necessary to take into account hormonally active ovarian tumors, as well as adrenal cancers. It is important to exclude other causes of hyperandrogenism, e.g. endocrinopathies (acromegaly or hypothyroidism), or iatrogenic and idiopathic factors. In order to make the diagnosis and implement the proper treatment method faster, an interdisciplinary team of physicians specializing in endocrinology, gynecology and oncology is crucial. This paper contains a study of two cases concerning Leydig cell ovarian tumors in women of postmenopausal age with symptoms of masculinization and hirsutism.

[1]  G. Jakiel,et al.  Sertoli-Leydig cell tumour (SLCT) – the case of a 15 cm diameter ovarian tumour with negative markers and absent hormonal symptoms , 2019, Journal of Health Inequalities.

[2]  M. Desouki Sex Cord-Stromal Tumors of the Ovary , 2019, Gynecologic and Obstetric Pathology, Volume 2.

[3]  I. Ray-Coquard,et al.  Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  Zhe Zhang,et al.  An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism , 2018, Medicine.

[5]  S. Ajith,et al.  Postmenopausal hyperandrogenism of ovarian origin: A clinicopathologic study of five cases , 2016, Journal of mid-life health.

[6]  D. Glintborg,et al.  Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours , 2015, BMJ Case Reports.

[7]  F. Keleştimur,et al.  Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. , 2012, Human reproduction update.

[8]  F. Laspas,et al.  Leydig cell tumour of the ovary localised with Positron Emission Tomography/Computed Tomography , 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[9]  V. Surabhi,et al.  Clinical syndromes associated with ovarian neoplasms: a comprehensive review. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[10]  D. Glintborg,et al.  An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[11]  G. Mikuz,et al.  Sertoli–Leydig cell tumours of the ovary and testis: a CGH and FISH study , 2007, Virchows Archiv.

[12]  R. Reznek,et al.  Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women? , 2003, Clinical endocrinology.